Internal Medicine, Infectious Disease · Van Nuys, CA
NPI
1740291301
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
14349 Victory Blvd Ste 204
Van Nuys, CA, 91401
Phone (818) 334-7305
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
1,260 services
Medicare patients, 2024
282
Average age 73
Drug cost, 2024
$51K
76 prescriptions
Company payments, 2025
$516
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meher F Tabatabai was code 99232 (hospital e&m - subsequent), 793 times for 212 patients. In total Meher F Tabatabai billed 1,260 services in 3 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 793 | 212 | $58.95 | $47K |
| 99223 Hospital E&M - Initial | Facility | 242 | 219 | $129.07 | $31K |
| 99233 Hospital E&M - Subsequent | Facility | 225 | 68 | $88.57 | $20K |
By year: 2022 $137K for 1,639 services; 2023 $118K for 1,348 services; 2024 $98K for 1,260 services.
Medicare prescription drug claims, 2024
In 2024, the drug Meher F Tabatabai prescribed most often to Medicare patients was Efavirenz, with 13 prescriptions and refills. In total Meher F Tabatabai wrote 76 Medicare prescriptions that cost $51K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Efavirenz Generic | 13 | 13 | Under 11 | $11K |
| Lamivudine-Zidovudine Lamivudine/Zidovudine | 13 | 13 | Under 11 | $8,557 |
Brand drugs: 11 claims; generic drugs: 65 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meher F Tabatabai $516 ($516 in general payments such as food, travel and fees) from 7 companies. The largest payer was Shionogi Inc with $155.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.